NPI: 1932561198 · EL CAJON, CA 92020 · Federally Qualified Health Center (FQHC) · NPI assigned 03/25/2016
Authorized official ROMAN, RICARDO controls 20+ related entities in our dataset. Read more
| Authorized Official | ROMAN, RICARDO (CFO) |
| NPI Enumeration Date | 03/25/2016 |
Other providers sharing the same authorized official: ROMAN, RICARDO
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 56,847 | $8.34M |
| 2019 | 88,068 | $9.27M |
| 2020 | 146,806 | $9.32M |
| 2021 | 187,219 | $15.21M |
| 2022 | 163,815 | $14.39M |
| 2023 | 226,929 | $19.95M |
| 2024 | 201,211 | $20.57M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 415,111 | 302,028 | $84.21M |
| 00003 | Internal/system code - not a standard HCPCS code | 42,332 | 30,686 | $11.90M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 63,755 | 59,641 | $114K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 12,200 | 12,175 | $87K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 93,686 | 84,724 | $76K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,898 | 3,348 | $69K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 2,161 | 1,864 | $54K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 8,185 | 5,915 | $53K |
| V2020 | Frames, purchases | 11,701 | 11,684 | $47K |
| 90834 | Psychotherapy, 45 minutes with patient | 7,054 | 6,289 | $44K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 6,170 | 6,150 | $40K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 7,980 | 7,969 | $31K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 21,446 | 20,497 | $25K |
| 0004A | 365 | 365 | $24K | |
| 92015 | Determination of refractive state | 17,733 | 17,695 | $23K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1,798 | 1,066 | $20K |
| 0001A | 301 | 292 | $19K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 1,262 | 1,165 | $19K |
| 0002A | 283 | 278 | $18K | |
| 0124A | 232 | 221 | $14K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,574 | 3,571 | $13K |
| 93000 | 5,904 | 5,854 | $12K | |
| 90791 | Psychiatric diagnostic evaluation | 2,124 | 2,106 | $12K |
| 0013A | 175 | 175 | $12K | |
| G0470 | Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | 170 | 132 | $10K |
| 98940 | 2,154 | 1,643 | $9K | |
| 92341 | 1,866 | 1,865 | $8K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 126 | 104 | $8K |
| 0071A | 94 | 91 | $6K | |
| 0072A | 85 | 85 | $6K | |
| 97161 | 108 | 107 | $4K | |
| 92250 | 6,508 | 6,506 | $4K | |
| 0154A | 125 | 125 | $4K | |
| G9920 | Screening performed and negative | 1,215 | 1,206 | $3K |
| 96156 | 167 | 154 | $3K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2,003 | 1,826 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,292 | 1,290 | $3K |
| G0469 | Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit | 50 | 45 | $3K |
| J3490 | Unclassified drugs | 158 | 150 | $3K |
| 90832 | Psychotherapy, 30 minutes with patient | 3,794 | 3,588 | $3K |
| 99401 | 717 | 710 | $3K | |
| 90480 | 713 | 712 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,935 | 3,888 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,928 | 3,882 | $2K |
| H1003 | Prenatal care, at-risk enhanced service; education | 210 | 179 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1,283 | 1,283 | $2K |
| 0173A | 73 | 71 | $2K | |
| 81025 | 8,354 | 8,116 | $2K | |
| 97803 | 4,114 | 4,093 | $2K | |
| 0012A | 28 | 28 | $2K | |
| 0081A | 54 | 54 | $2K | |
| 98960 | 1,201 | 1,113 | $1K | |
| 90651 | 2,256 | 2,256 | $981.08 | |
| 0134A | 14 | 14 | $938.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3,314 | 3,301 | $799.24 |
| 58300 | 16 | 12 | $489.04 | |
| 11721 | 326 | 326 | $487.54 | |
| 99402 | 118 | 116 | $413.27 | |
| 80061 | Lipid panel | 6,380 | 6,378 | $336.13 |
| 80053 | Comprehensive metabolic panel | 6,755 | 6,737 | $328.81 |
| 86592 | 2,946 | 2,926 | $292.90 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 5,706 | 5,696 | $247.92 |
| 90686 | 6,186 | 6,185 | $220.46 | |
| 81002 | 9,406 | 6,982 | $213.68 | |
| 86480 | 2,047 | 2,046 | $209.24 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,574 | 7,528 | $129.47 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,999 | 1,942 | $119.24 |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 151 | 148 | $117.74 |
| 84443 | Thyroid stimulating hormone (TSH) | 6,185 | 6,178 | $100.38 |
| 86803 | 2,271 | 2,269 | $97.08 | |
| A4267 | Contraceptive supply, condom, male, each | 83 | 82 | $44.91 |
| 81003 | 2,860 | 2,824 | $43.82 | |
| 87210 | 2,291 | 2,279 | $37.03 | |
| 58301 | 13 | 12 | $37.02 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4,578 | 4,499 | $34.69 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 133 | 129 | $21.80 |
| 86704 | 1,189 | 1,189 | $21.66 | |
| 81015 | 3,111 | 3,060 | $20.38 | |
| 86706 | 1,576 | 1,576 | $19.02 | |
| 87340 | 705 | 705 | $18.24 | |
| 36415 | Collection of venous blood by venipuncture | 5,557 | 5,284 | $15.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,059 | 1,054 | $14.03 |
| 99000 | 8,716 | 8,540 | $10.89 | |
| 82043 | 704 | 704 | $5.08 | |
| 96127 | 3,692 | 3,511 | $4.81 | |
| 82570 | 946 | 942 | $4.69 | |
| 99173 | 4,627 | 4,614 | $2.34 | |
| X3904 | 15,432 | 7,840 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,508 | 2,503 | $0.00 |
| 90710 | 791 | 791 | $0.00 | |
| 2028F | 1,680 | 1,660 | $0.00 | |
| 90670 | 2,768 | 2,768 | $0.00 | |
| 84439 | 264 | 263 | $0.00 | |
| 90648 | 530 | 530 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,898 | 1,882 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,998 | 2,954 | $0.00 |
| 90461 | 3,624 | 3,619 | $0.00 | |
| 83540 | 711 | 708 | $0.00 | |
| 90707 | 722 | 722 | $0.00 | |
| 99404 | 479 | 476 | $0.00 | |
| 90756 | 2,011 | 2,011 | $0.00 | |
| 90713 | 490 | 490 | $0.00 | |
| 84450 | 625 | 623 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 11,872 | 10,596 | $0.00 |
| 90750 | 230 | 230 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5,985 | 5,968 | $0.00 |
| 91322 | 139 | 138 | $0.00 | |
| 80354 | 228 | 224 | $0.00 | |
| Z6200 | 633 | 632 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5,386 | 5,384 | $0.00 |
| 91312 | 70 | 70 | $0.00 | |
| X4110 | 224 | 101 | $0.00 | |
| 85610 | 130 | 122 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,677 | 3,676 | $0.00 |
| Z6400 | 3,603 | 2,996 | $0.00 | |
| 90715 | 2,092 | 2,090 | $0.00 | |
| 82947 | 872 | 862 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2,418 | 2,396 | $0.00 |
| 96160 | 2,910 | 2,896 | $0.00 | |
| 92134 | 959 | 958 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,951 | 2,919 | $0.00 |
| 2022F | 198 | 198 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,167 | 1,164 | $0.00 |
| 90700 | 1,083 | 1,083 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2,663 | 2,662 | $0.00 |
| 90633 | 2,727 | 2,675 | $0.00 | |
| 59425 | 70 | 64 | $0.00 | |
| 82565 | 29 | 29 | $0.00 | |
| 90785 | 441 | 434 | $0.00 | |
| Z6308 | 39 | 37 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 176 | 176 | $0.00 |
| 90734 | 487 | 487 | $0.00 | |
| 20611 | 26 | 14 | $0.00 | |
| Z6304 | 1,024 | 1,000 | $0.00 | |
| 90837 | Psychotherapy, 53 minutes with patient | 507 | 476 | $0.00 |
| 91321 | 517 | 517 | $0.00 | |
| 82248 | 65 | 49 | $0.00 | |
| 69209 | 299 | 291 | $0.00 | |
| 91308 | 47 | 47 | $0.00 | |
| 90681 | 499 | 498 | $0.00 | |
| 99201 | 200 | 200 | $0.00 | |
| Z6300 | 530 | 530 | $0.00 | |
| 84460 | 608 | 606 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 458 | 447 | $0.00 |
| 99442 | 210 | 205 | $0.00 | |
| Z6500 | 70 | 70 | $0.00 | |
| Z6414 | 51 | 50 | $0.00 | |
| 84156 | 69 | 66 | $0.00 | |
| 90687 | 54 | 54 | $0.00 | |
| 99215 | Prolong outpt/office vis | 134 | 134 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17 | 17 | $0.00 |
| 82247 | 65 | 49 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 296 | 285 | $0.00 |
| 80076 | 12 | 12 | $0.00 | |
| Z6208 | 30 | 28 | $0.00 | |
| 92553 | 448 | 443 | $0.00 | |
| 90658 | 41 | 41 | $0.00 | |
| 97164 | 168 | 164 | $0.00 | |
| 90380 | 61 | 61 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 322 | 322 | $0.00 |
| L1812 | Knee orthosis, elastic with joints, prefabricated, off-the-shelf | 56 | 56 | $0.00 |
| 82274 | 32 | 32 | $0.00 | |
| 90685 | 23 | 23 | $0.00 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 41 | 39 | $0.00 |
| L1820 | Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 45 | 45 | $0.00 |
| 90661 | 349 | 348 | $0.00 | |
| 90653 | 29 | 29 | $0.00 | |
| 90714 | 41 | 41 | $0.00 | |
| 90746 | 30 | 30 | $0.00 | |
| 59025 | Fetal non-stress test | 29 | 24 | $0.00 |
| 84550 | 101 | 101 | $0.00 | |
| 99188 | 58 | 58 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 270 | 267 | $0.00 |
| 10060 | 12 | 12 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 30 | 29 | $0.00 |
| 90473 | 36 | 36 | $0.00 | |
| 3078F | 112 | 112 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 18 | 18 | $0.00 |
| 85007 | 25 | 25 | $0.00 | |
| Z1034 | 11,593 | 8,602 | $0.00 | |
| 90680 | 1,883 | 1,883 | $0.00 | |
| 86140 | 304 | 301 | $0.00 | |
| Z6406 | 887 | 837 | $0.00 | |
| Z6410 | 985 | 966 | $0.00 | |
| 85651 | 794 | 789 | $0.00 | |
| 83550 | 639 | 636 | $0.00 | |
| 90674 | 539 | 539 | $0.00 | |
| 99381 | 1,021 | 1,016 | $0.00 | |
| Z1038 | 712 | 710 | $0.00 | |
| 36416 | 146 | 127 | $0.00 | |
| 90619 | 622 | 622 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 14,400 | 14,338 | $0.00 |
| X3924 | 6,732 | 5,770 | $0.00 | |
| 90696 | 553 | 553 | $0.00 | |
| 82951 | 1,365 | 1,358 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 485 | 480 | $0.00 |
| 90698 | 1,516 | 1,516 | $0.00 | |
| Z6204 | 1,320 | 1,257 | $0.00 | |
| 87081 | 725 | 723 | $0.00 | |
| 85018 | 4,564 | 4,537 | $0.00 | |
| 90716 | 971 | 971 | $0.00 | |
| 82728 | 603 | 602 | $0.00 | |
| Z6402 | 763 | 762 | $0.00 | |
| 97802 | 1,165 | 1,164 | $0.00 | |
| 87070 | 1,474 | 1,460 | $0.00 | |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 16 | 16 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,757 | 2,715 | $0.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 72 | 72 | $0.00 |
| 90677 | 1,119 | 1,118 | $0.00 | |
| 81001 | 309 | 303 | $0.00 | |
| 91315 | 65 | 65 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,491 | 1,454 | $0.00 |
| 94760 | 1,114 | 1,045 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 199 | 199 | $0.00 |
| 99070 | 182 | 180 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1,167 | 1,163 | $0.00 |
| Z1032 | 1,186 | 1,174 | $0.00 | |
| 91317 | 61 | 61 | $0.00 | |
| 99406 | 808 | 789 | $0.00 | |
| X3908 | 2,018 | 1,445 | $0.00 | |
| 92551 | 7,616 | 7,581 | $0.00 | |
| 90744 | 1,464 | 1,464 | $0.00 | |
| 3074F | 113 | 113 | $0.00 | |
| 20610 | 1,971 | 1,826 | $0.00 | |
| 90381 | 58 | 58 | $0.00 | |
| 2023F | 1,141 | 1,138 | $0.00 | |
| X3906 | 167 | 163 | $0.00 | |
| 90688 | 179 | 179 | $0.00 | |
| X4304 | 137 | 67 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 54 | 44 | $0.00 |
| 92002 | 106 | 106 | $0.00 | |
| 97162 | 277 | 275 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 14 | 14 | $0.00 |
| 99459 | 325 | 324 | $0.00 | |
| 90739 | 106 | 106 | $0.00 | |
| 99441 | 227 | 220 | $0.00 | |
| X3910 | 138 | 108 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 124 | 117 | $0.00 |
| 80050 | General health panel | 60 | 60 | $0.00 |
| 99385 | 39 | 39 | $0.00 | |
| 90697 | 1,427 | 1,426 | $0.00 | |
| 87428 | 3,082 | 3,049 | $0.00 | |
| 99443 | 12 | 12 | $0.00 | |
| 3008F | 114 | 114 | $0.00 | |
| 90732 | 82 | 82 | $0.00 | |
| 90656 | 672 | 672 | $0.00 | |
| 3072F | 113 | 113 | $0.00 | |
| 11055 | 13 | 12 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 60 | 56 | $0.00 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 49 | 49 | $0.00 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 111 | 111 | $0.00 |
| 4000F | 57 | 57 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 183 | 181 | $0.00 |
| 91301 | 19 | 19 | $0.00 | |
| X3902 | 79 | 50 | $0.00 | |
| 90694 | 143 | 142 | $0.00 | |
| 0011A | 19 | 19 | $0.00 | |
| 99383 | 12 | 12 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 69 | 67 | $0.00 |
| 83690 | 67 | 67 | $0.00 | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 29 | 29 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 16 | 15 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 28 | 28 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 38 | 36 | $0.00 |
| A9300 | Exercise equipment | 12 | 12 | $0.00 |
| 90723 | 21 | 21 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 15 | 14 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 27 | 14 | $0.00 |
| 96161 | 85 | 85 | $0.00 |